Viking Fund Management LLC Biogen Inc. Transaction History

Viking Fund Management LLC

  • $605 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 26, 2021
SELL
$242.95 - $284.63 $570,932 - $668,880
-2,350 Closed
0 $0
Q2 2020

Jul 27, 2020
BUY
$258.66 - $342.55 $90,531 - $119,892
350 Added 17.5%
2,350 $629,000
Q2 2019

Jul 16, 2019
BUY
$219.29 - $241.72 $219,290 - $241,720
1,000 Added 100.0%
2,000 $468,000
Q4 2018

Jan 23, 2019
BUY
$278.5 - $352.75 $278,500 - $352,750
1,000 New
1,000 $301,000

Others Institutions Holding BIIB

# of Institutions
1,037
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Viking Fund Management LLC Portfolio

Follow Viking Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Viking Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Viking Fund Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email